What does CUSIP 488445206 represent in this 13F holders report?

CUSIP 488445206 is the security identifier for ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in Q2 2023?

69 institutional investors reported ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)

CUSIP: 488445206

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 56,066,823
Total 13F shares: 8,153,478
Share change: +1,993,469
Total reported value: $41,582,121
Put/Call ratio: 44%
Price per share: $5.10
Number of holders: 69
Value change: +$9,633,583
Number of buys: 42
Number of sells: 27

Quarterly Holders Quick Answers

What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 488445206:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Samuel J. Braun	3/4/5	10%+ Owner	— class O/S missing	3,153,000	$15,636,043	—	13 May 2021	3/4/5
VANGUARD GROUP INC	13F	Company	2.6%	1,472,793	$8,100,361	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	1.1%	603,178	$3,317,480	—	31 Mar 2023	13F
Laurion Capital Management LP	13F	Company	1%	571,200	$3,141,600	—	31 Mar 2023	13F
Janney Montgomery Scott LLC	13F	Company	0.94%	528,755	$2,908,000	—	31 Mar 2023	13F
GREAT POINT PARTNERS LLC	13F	Company	0.62%	347,824	$1,913,032	—	31 Mar 2023	13F
Retirement Planning Co of New England, Inc.	13F	Company	0.58%	327,583	$1,801,707	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	319,018	$1,754,599	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.36%	201,172	$1,106,446	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.33%	184,812	$1,016,466	—	31 Mar 2023	13F
Mystic Asset Management, Inc.	13F	Company	0.32%	177,533	$976,432	—	31 Mar 2023	13F
Travis C. Mickle	3/4/5	President & CEO, Director	— class O/S missing	171,774	$851,845	—	25 May 2022	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	0.27%	153,053	$842,000	—	31 Mar 2023	13F
Kovack Advisors, Inc.	13F	Company	0.22%	122,822	$675,521	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.2%	114,626	$630,444	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.2%	110,040	$605,220	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.19%	103,800	$571,000	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	95,143	$523,287	—	31 Mar 2023	13F
Arete Wealth Advisors, LLC	13F	Company	0.15%	82,290	$453,000	—	31 Mar 2023	13F
Stratos Wealth Partners, LTD.	13F	Company	0.13%	70,200	$386,100	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.1%	58,496	$321,728	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.1%	55,708	$306,395	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.1%	53,882	$296,351	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	49,929	$274,610	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.09%	48,186	$265,023	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	32,831	$180,571	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	31,186	$171,523	—	31 Mar 2023	13F
Richard W. Pascoe	3/4/5	Chief Executive Officer, Director	— class O/S missing	29,973	$148,639	—	09 Mar 2023	3/4/5
Raymond James Financial Services Advisors, Inc.	13F	Company	0.05%	26,328	$144,804	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.04%	20,257	$111,414	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.03%	19,317	$106,244	—	31 Mar 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.03%	17,972	$98,846	—	31 Mar 2023	13F
LPL Financial LLC	13F	Company	0.03%	16,781	$92,296	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.03%	16,747	$92,109	—	31 Mar 2023	13F
City State Bank	13F	Company	0.03%	14,224	$78,000	—	31 Mar 2023	13F
Kingsview Wealth Management, LLC	13F	Company	0.02%	12,120	$66,660	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	11,139	$61,265	—	31 Mar 2023	13F
Lighthouse Investment Partners, LLC	13F	Company	0.02%	10,658	$58,619	—	31 Mar 2023	13F
David S. Tierney	3/4/5	Director	— class O/S missing	10,835	$53,732	—	09 Mar 2023	3/4/5
Balefire, LLC	13F	Company	0.02%	10,217	$49,859	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	6,225	$34,237	—	31 Mar 2023	13F
NewEdge Advisors, LLC	13F	Company	0.01%	5,200	$28,600	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,077	$27,924	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	4,139	$22,765	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	4,137	$22,753	—	31 Mar 2023	13F
CNB Bank	13F	Company	0.01%	2,938	$16,159	—	31 Mar 2023	13F
FMR LLC	13F	Company	0%	2,114	$11,628	—	31 Mar 2023	13F
Stephens Consulting, LLC	13F	Company	0%	2,000	$11,000	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,187	$7,000	—	31 Mar 2023	13F
Tortoise Investment Management, LLC	13F	Company	0%	1,200	$6,600	—	31 Mar 2023	13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q2 2023

As of 30 Jun 2023, ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,153,478 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Janney Montgomery Scott LLC, Retirement Planning Co of New England, Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, Mystic Asset Management, Inc., and RENAISSANCE TECHNOLOGIES LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.